Assessment of COVID-19 in Tearfilm
NCT04579458 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2021-02-05
Summary
To assess the co-relation of COVID-19 in nasopharyngeal swabs and tears or saliva, and to determine duration of COVID-19 activity in ocular fluid and saliva by serial tests over 3 months.
Conditions
- Covid19
- Ophthalmopathy
- Eye Diseases
Interventions
- PROCEDURE
-
Collection of tears and saliva.
Saliva and ocular tears will be collected.
Sponsors & Collaborators
-
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
Sapna Gangaputra · Vanderbilt Eye Institiute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-28
- Primary Completion
- 2021-01-22
- Completion
- 2021-01-22
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease
NCT04346160 ·Status: UNKNOWN
-
Effect of Lifitegrast 5% on Tear Film Markers
NCT03952481 ·Status: WITHDRAWN ·Phase: PHASE4
-
Metabolites of Tear Fluid
NCT03389282 ·Status: UNKNOWN
-
Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay
NCT00487643 ·Status: COMPLETED
-
Evaluation of Safety and Tolerability of Investigational Ocular Lubricants
NCT05888519 ·Status: COMPLETED ·Phase: NA
-
SARS Cov-2 in Conjunctival Secretion in COVID-19 Patients
NCT04402853 ·Status: COMPLETED
-
Clinical Evaluation of the InflammaDry Device for Detecting Dry Eye
NCT01692964 ·Status: COMPLETED
-
Study Evaluating Techniques for Measuring Tear Production
NCT05497479 ·Status: COMPLETED ·Phase: PHASE1
-
Tear Film Markers in Dry Eye Syndrome
NCT04515329 ·Status: WITHDRAWN ·Phase: PHASE4
-
Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ Use
NCT03274999 ·Status: TERMINATED ·Phase: NA
-
Keratometric Tear Breakup Time and Fluorescein Tear Breakup Time
NCT00854906 ·Status: COMPLETED
-
Evaluation of the Safety and Tolerability of Ocular Lubricants
NCT06571656 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
NCT01010282 ·Status: COMPLETED ·Phase: NA
-
Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics
NCT00831961 ·Status: COMPLETED
-
COVID-19 Search in Conjunctival Cells
NCT04364594 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Reflex Tear Production
NCT06565624 ·Status: TERMINATED ·Phase: NA
-
A Study To Investigate The Effects Of A Low Humidity Environment And Visual Tasking On Tear Film Protein Composition
NCT02005874 ·Status: COMPLETED
-
Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation
NCT02385292 ·Status: COMPLETED ·Phase: NA
-
A Prospective Clinical Study Assessing the Effects of Tetracycline Antibiotic on Tear Film and Tear Lipid Composition Within a Population of Patients Diagnosed With Blepharitis and Dry Eye Disease
NCT00355459 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye
NCT00514852 ·Status: COMPLETED ·Phase: NA
-
Study of VVN001 Ophthalmic Solution in Dry Eye Disease
NCT04556838 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears
NCT00266734 ·Status: COMPLETED ·Phase: NA
-
Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
NCT04198740 ·Status: RECRUITING
-
Point of Care Testing of Inflammatory Markers in Tears
NCT02315079 ·Status: COMPLETED
-
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
NCT06544694 ·Status: COMPLETED ·Phase: PHASE3